[1] |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315: 801-810.doi:10.1001/jama.2016.0287.
|
[2] |
Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis[J]. Virulence, 2014, 5: doi:10.4161/viru.27372.
|
[3] |
Gaieski DF, Edwards JM, Kallan MJ, et al. Benchmark-ing the incidence and mortality of severe sepsis in the united states[J]. Crit Care Med, 2013, 41: 1167-1174.doi:10.1097/CCM.0b013e31827c09f8.
|
[4] |
Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure[J]. JAMA, 2011, 306: 2594-2605.doi:10.1001/jama.2011.1829.
|
[5] |
Faix JD. Biomarkers of sepsis[J]. Crit Rev Clin Lab Sci, 2013, 50: 23-36.doi:10.3109/10408363.2013.764490.
|
[6] |
Rose-John S. Il-6 trans-signaling via the soluble il-6 receptor: Importance for the pro-inflammatory activities of il-6[J]. Int J Biol Sci, 2012, 8: 1237-1247.doi:10.7150/ijbs.4989.
|
[7] |
Becker C, Fantini MC, Schramm C, et al. Tgf-beta suppresses tumor progression in colon cancer by inhibition of il-6 trans-signaling[J]. Immunity, 2004, 21: 491-501.
|
[8] |
Le T-TT, Karmouty-Quintana H, Melicoff E, et al. Blockade of il-6 trans signaling attenuates pulmonary fibrosis[J]. J Immunol, 2014, 193: 3755-3768.doi:10.4049/jimmunol.1302470.
|
[9] |
程宇航, 郑毅, 王丽芳,等. 抽动秽语综合征患者血清自身抗体与可溶性白介素-6受体表达增高[J]. 基础医学与临床,2010, 30: 113-116.doi:10.16352/j.issn.1001-6325.2010.02.025.
|
[10] |
Rittirsch D, Huber-Lang MS, Flierl MA, et al. Immunodesign of experimental sepsis by cecal ligation and puncture[J]. Nat Protoc, 2009, 4: 31-36.doi:10.1038/nprot.2008.214.
|
[11] |
Tanaka T, Kishimoto T. The biology and medical implications of interleukin-6[J]. Cancer Immunol Res, 2014, 2(4): 288-294.doi:10.1158/2326-6066.CIR-14-0022.
|
[12] |
Sackett SD, Otto T, Mohs A, et al. Myeloid cells require gp130 signaling for protective anti-inflammatory functions during sepsis[J]. FASEB J, 2019, 33: 6035-6044.doi:10.1096/fj.201802118R.
|
[13] |
Rose-John S. The soluble interleukin 6 receptor: advanced therapeutic options in inflammation[J]. Clin Pharmacol Ther, 2017, 102: 591-598.doi:10.1002/cpt.782.
|
[14] |
龚非力. 医学免疫学[M].3 版. 北京: 人民卫生出版社,2011:115-124.
|